Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects

Kidney International

Volumn 91, Issue 2, 2017, Pages 435-442

  Soleimani, Alireza ^a   Zarrati Mojarrad, Malihe ^a   Bahmani, Fereshteh ^a   Taghizadeh, Mohsen ^a   Ramezani, Mohammad ^a   Tajabadi Ebrahimi, Maryam ^b   Jafari, Parvaneh ^c   Esmaillzadeh, Ahmad ^d,e,f   Asemi, Zatollah ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

hemodialysis; metabolic status; probiotic supplementation

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; MALONALDEHYDE; PLACEBO; PROBIOTIC AGENT; TRACE ELEMENT; AUTACOID; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; BIFIDOBACTERIUM BIFIDUM; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG CAPSULE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS PATIENT; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; IRON BINDING CAPACITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PARALLEL DESIGN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SUBJECTIVE GLOBAL ASSESSMENT SCORE; TREATMENT DURATION; AGED; BLOOD; DIABETIC NEPHROPATHIES; DOUBLE BLIND PROCEDURE; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; HEMODIALYSIS; INTESTINE FLORA; IRAN; METABOLISM; MICROBIOLOGY; PROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; BIFIDOBACTERIUM BIFIDUM; BIOMARKERS; BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; IRAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROBIOTICS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85008324944     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.09.040     Document Type: Article

References (51)

1. Ghimire, M., Pahari, B., Das, G., et al. Prevalence of peripheral arterial disease (PAD) in end stage renal disease (ESRD) patients on hemodialysis: a study from central Nepal. Kathmandu Univ Med J 12 (2014), 181–184.
2. Gupta, A., Gupta, P., Biyani, M., Targeted therapies in diabetic nephropathy: an update. J Nephrol 24 (2011), 686–695.
3. Martin-Del-Campo, F., Gonzalez-Espinoza, L., Rojas-Campos, E., et al. Conventional nutritional counselling maintains nutritional status of patients on continuous ambulatory peritoneal dialysis in spite of systemic inflammation and decrease of residual renal function. Nephrology (Carlton) 14 (2009), 493–498.
4. Kotur-Stevuljevic, J., Simic-Ogrizovic, S., Dopsaj, V., et al. A hazardous link between malnutrition, inflammation and oxidative stress in renal patients. Clin Biochem 45 (2012), 1202–1205.
5. Sipahi, S., Gungor, O., Gunduz, M., et al. The effect of oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine on wound healing: a retrospective analysis of diabetic haemodialysis patients. BMC Nephrol, 14, 2013, 8.
6. Kalantar-Zadeh, K., Ikizler, T.A., Block, G., et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42 (2003), 864–881.
7. Stenvinkel, P., Heimburger, O., Lindholm, B., et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15 (2000), 953–960.
8. Simenhoff, M.L., Dunn, S.R., Zollner, G.P., et al. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab 22 (1996), 92–96.
9. Dunn, S.R., Simenhoff, M.L., Ahmed, K.E., et al. Effect of oral administration of freeze-dried Lactobacillus acidophilus on small bowel bacterial overgrowth in patients with end stage kidney disease: reducing uremic toxins and improving nutrition. Int Dairy J 8 (1998), 545–553.
10. Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 32 (2016), 315–320.
11. Karamali, M., Dadkhah, F., Sadrkhanlou, M., et al. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Metab 42 (2016), 234–241.
12. Falasca, K., Vecchiet, J., Ucciferri, C., et al. Effect of probiotic supplement on cytokine levels in HIV-infected individuals: a preliminary study. Nutrients 7 (2015), 8335–8347.
13. Vaghef-Mehrabany, E., Homayouni-Rad, A., Alipour, B., et al. Effects of probiotic supplementation on oxidative stress indices in women with rheumatoid arthritis: a randomized double-blind clinical trial. J Am Coll Nutr 35 (2016), 291–299.
14. Kullisaar, T., Zilmer, M., Mikelsaar, M., et al. Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol 72 (2002), 215–224.
15. Ma, X., Hua, J., Li, Z., Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 49 (2008), 821–830.
16. Esteve, E., Ricart, W., Fernandez-Real, J.M., Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?. Curr Opin Clin Nutr Metab Care 14 (2011), 483–490.
17. Firouzi, S., Majid, H.A., Ismail, A., et al. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial. [e-pub ahead of print] Eur J Nutr, 2016.
18. Asemi, Z., Zare, Z., Shakeri, H., et al. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 63 (2013), 1–9.
19. Andreasen, A.S., Larsen, N., Pedersen-Skovsgaard, T., et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 104 (2010), 1831–1838.
20. Fouque, D., Kalantar-Zadeh, K., Kopple, J., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73 (2008), 391–398.
21. Shinohara, K., Shoji, T., Emoto, M., et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13 (2002), 1894–1900.
22. Shi, H., Kokoeva, M.V., Inouye, K., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116 (2006), 3015–3025.
23. Yadav, H., Lee, J.H., Lloyd, J., et al. Beneficial metabolic effects of a probiotic via butyrate induced GLP-1 secretion. J Biol Chem 288 (2013), 25088–25097.
24. Ainsworth, B.E., Haskell, W.L., Whitt, M.C., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32 (2000), S498–S504.
25. Pisprasert, V., Ingram, K.H., Lopez-Davila, M.F., et al. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 36 (2013), 845–853.
26. Tatsch, E., Bochi, G.V., Pereira Rda, S., et al. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 44 (2011), 348–350.
27. Benzie, I.F., Strain, J.J., The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239 (1996), 70–76.
28. Beutler, E., Gelbart, T., Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105 (1985), 581–584.
29. Janero, D.R., Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9 (1990), 515–540.
30. Nursal, T.Z., Noyan, T., Tarim, A., et al. A new weighted scoring system for Subjective Global Assessment. Nutrition 21 (2005), 666–671.
31. Daugirdas, J.T., Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 4 (1993), 1205–1213.
32. d'Ettorre, G., Ceccarelli, G., Giustini, N., et al. Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the “Probio-HIV” Clinical Trial. PLoS One, 10, 2015, e0137200.
33. Zarrati, M., Salehi, E., Nourijelyani, K., et al. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet. J Am Coll Nutr 33 (2014), 417–425.
34. Cheng, C.P., Tsai, S.W., Chiu, C.P., et al. The effect of probiotic-fermented soy milk on enhancing the NO-mediated vascular relaxation factors. J Sci Food Agric 93 (2013), 1219–1225.
35. Meyer, T.W., Hostetter, T.H., Uremia. N Engl J Med 357 (2007), 1316–1325.
36. Hyun, H.S., Paik, K.H., Cho, H.Y., p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis. Korean J Pediatr 56 (2013), 159–164.
37. Sun, C.Y., Hsu, H.H., Wu, M.S., p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. Nephrol Dial Transplant 28 (2013), 70–78.
38. Glorieux, G., Vanholder, R., Lameire, N., Uraemic retention and apoptosis: what is the balance for the inflammatory status in uraemia?. Eur J Clin Invest 33 (2003), 631–634.
39. Melamed, M.L., Plantinga, L., Shafi, T., et al. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol, 14, 2013, 134.
40. Meijers, B.K., Claes, K., Bammens, B., et al. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin J Am Soc Nephrol 5 (2010), 1182–1189.
41. Hida, M., Aiba, Y., Sawamura, S., et al. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin®, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 74 (1996), 349–355.
42. Nakabayashi, I., Nakamura, M., Kawakami, K., et al. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant 26 (2011), 1094–1098.
43. Bahmani, F., Tajadadi-Ebrahimi, M., Kolahdooz, F., et al. The consumption of synbiotic bread containing Lactobacillus sporogenes and inulin affects nitric oxide and malondialdehyde in patients with type 2 diabetes mellitus: randomized, double-blind, placebo-controlled trial. J Am Coll Nutr, 2015, 1–8.
44. den Elzen, W.P., van Manen, J.G., Boeschoten, E.W., et al. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. Nephrol Dial Transplant 21 (2006), 1588–1595.
45. Honda, H., Qureshi, A.R., Heimburger, O., et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47 (2006), 139–148.
46. Taccone-Gallucci, M., Noce, A., Bertucci, P., et al. Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients. J Trace Elem Med Biol 24 (2010), 27–30.
47. Sadrzadeh-Yeganeh, H., Elmadfa, I., Djazayery, A., et al. The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr 103 (2010), 1778–1783.
48. Komers, R., Anderson, S., Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 284 (2003), F1121–F1137.
49. Matthews, G.M., Howarth, G.S., Butler, R.N., Short-chain fatty acid modulation of apoptosis in the Kato III human gastric carcinoma cell line. Cancer Biol Ther 6 (2007), 1051–1057.
50. Roessler, A., Forssten, S.D., Glei, M., et al. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study. Clin Nutr 31 (2012), 22–29.
51. Valentini, L., Pinto, A., Bourdel-Marchasson, I., et al. Impact of personalized diet and probiotic supplementation on inflammation, nutritional parameters and intestinal microbiota - The “RISTOMED project”: Randomized controlled trial in healthy older people. Clin Nutr 34 (2015), 593–602.